Regend Therapeutics
Clinical trials sponsored by Regend Therapeutics, explained in plain language.
-
Experimental cell injection aims to heal damaged kidneys
Disease control Recruiting nowThis early-stage study is testing the safety of an experimental treatment called REGEND003, which contains human kidney repair cells. Researchers want to see if injecting these cells directly into the kidneys is safe and tolerable for people with type 2 diabetes and chronic kidne…
Phase: PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 22:55 UTC
-
First-of-its-Kind stem cell trial offers hope for kids with rare lung damage
Disease control Recruiting nowThis early-stage study is testing whether a patient's own airway stem cells can help treat children with bronchiolitis obliterans, a rare and serious lung disease that often follows a severe infection. Researchers will give 12 children a single treatment and closely monitor their…
Phase: EARLY_PHASE1 • Sponsor: Regend Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC